BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

391 related articles for article (PubMed ID: 7019435)

  • 1. Prospective carbohydrate metabolism studies in women using a low-estrogen oral contraceptive for one year.
    Spellacy WN; Birk SA; Buggie J; Buhi WC
    J Reprod Med; 1981 Jun; 26(6):295-8. PubMed ID: 7019435
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Glucose and insulin levels after six months of treatment with a triphasic oral contraceptive containing ethinyl estradiol and norethindrone.
    Spellacy WN; Ellingson AB; Tsibris JC
    J Reprod Med; 1989 Aug; 34(8):540-2. PubMed ID: 2681750
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Influence of progestins on adverse effects of oral contraceptives].
    Wynn V
    Contracept Fertil Sex (Paris); 1985 Jan; 13(1 Suppl):425-30. PubMed ID: 12280210
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long-term profile of a new progestin.
    Lippman J
    Int J Fertil; 1992; 37 Suppl 4():218-22. PubMed ID: 1362189
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacodynamic effects of oral contraceptive steroids on biochemical markers for arterial thrombosis. Studies in non-diabetic women and in women with insulin-dependent diabetes mellitus.
    Petersen KR
    Dan Med Bull; 2002 Feb; 49(1):43-60. PubMed ID: 11894723
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effect of low-oestrogen combined pill, progestogen-only pill and medroxyprogesterone acetate on oral glucose tolerance test.
    Kamau RK; Maina FW; Kigondu C; Mati JK
    East Afr Med J; 1990 Aug; 67(8):550-5. PubMed ID: 2148146
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of oral contraceptives on carbohydrate metabolism.
    Wynn V; Godsland I
    J Reprod Med; 1986 Sep; 31(9 Suppl):892-7. PubMed ID: 3095547
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Low dosage oral contraception in women with previous gestational diabetes.
    Skouby SO; Mølsted-Pedersen L; Kühl C
    Obstet Gynecol; 1982 Mar; 59(3):325-8. PubMed ID: 6804901
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effects of two triphasic oral contraceptives on carbohydrate metabolism in women during 1 year of use.
    Spellacy WN; Ellingson AB; Tsibris JC
    Fertil Steril; 1989 Jan; 51(1):71-4. PubMed ID: 2642814
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Carbohydrate metabolism studies after one year of using an oral contraceptive containing gestodene and ethinyl estradiol.
    Spellacy WN; Tsibris AM; Tsibris JC; George S; Chez RA; O'Brien WF
    Contraception; 1994 Feb; 49(2):125-30. PubMed ID: 8143452
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Increased levels of activated factor VII and decreased plasma protein S activity and circulating thrombomodulin during use of oral contraceptives.
    Quehenberger P; Loner U; Kapiotis S; Handler S; Schneider B; Huber J; Speiser W
    Thromb Haemost; 1996 Nov; 76(5):729-34. PubMed ID: 8950781
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Carbohydrate metabolism in Gynanovlar 21 and Lyndiol 2.5 users.
    Kamal I; Zaki K; Rashad S
    Egypt Popul Fam Plann Rev; 1972 Jun; 5(1):67-77. PubMed ID: 12256028
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prospective study of carbohydrate metabolism in women using a triphasic oral contraceptive containing norethindrone and ethinyl estradiol for 3 months.
    Spellacy WN; Ellingson AB; Kotlik A; Tsibris JC
    Am J Obstet Gynecol; 1988 Oct; 159(4):877-9. PubMed ID: 3052079
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A 1-year randomized study to evaluate the effects of a dose reduction in oral contraceptives on lipids and carbohydrate metabolism: 20 microg ethinyl estradiol combined with 100 microg levonorgestrel.
    Skouby SO; Endrikat J; Düsterberg B; Schmidt W; Gerlinger C; Wessel J; Goldstein H; Jespersen J
    Contraception; 2005 Feb; 71(2):111-7. PubMed ID: 15707560
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Oral contraception, mechanical contraception, and carbohydrate and lipid metabolism: a two-year study.
    Pribicevic V; Skrabalo Z; Lipovac V; Trenc S; Zadjelovic J; Rajkovic Z
    Int J Fertil; 1979; 24(2):114-9. PubMed ID: 40904
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Carbohydrate metabolism during treatment with estrogen, progestogen, and low-dose oral contraceptives.
    Spellacy WN
    Am J Obstet Gynecol; 1982 Mar; 142(6 Pt 2):732-4. PubMed ID: 7039318
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Metabolic risks of oral contraception].
    Monier L
    Rev Int Pediatr; 1988 Feb; (178):64-5. PubMed ID: 12282576
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Potential advantages of triphasic combined oral contraceptives in the light of recent epidemiological and endocrinometabolic data].
    Gaspard U; Dubois M
    Contracept Fertil Sex (Paris); 1982 Sep; 10(9):551-60. PubMed ID: 12311606
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The influence of a sequential-type oral contraceptive with ethinylestradiol-sulfonate soft gelatin capsules and norethisterone acetate on carbohydrate metabolism during the first twelve months.
    Nikschick S; Göretzlehner G; Männchen E; Brachmann K
    Exp Clin Endocrinol; 1985 Jun; 85(3):257-62. PubMed ID: 3899684
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of oestrogen dose on whole blood platelet activation in women taking new low dose oral contraceptives.
    Norris LA; Bonnar J
    Thromb Haemost; 1994 Dec; 72(6):926-30. PubMed ID: 7740465
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.